Michael Hall Allen, M.D.
University of Colorado at Denver and Health Sciences Center
Effects of Nicotine Replacement Therapy on Agitation and Aggression in Schizophrenic Smokers

Rene Anand, Ph.D.
Louisiana State University Health Sciences Center Louisiana State University
Dysfunctional Modulation of Nicotinic Receptors in Schizophrenia

Celso Arango, M.D.
Hospital General Universitario Gregorio Maranon
Safety and Tolerability of Antipsychotic Drugs in Children and Adolescents

Alberto Ascherio, M.D., DrPH
Harvard School of Public Health, Harvard University
Prospective Study of Depression in a Large Cohort of Nurses

Sofia Avissar, Ph.D.
Ben Gurion University
Receptor G-Protein Desensitization Regulators: Involvement of Alterations in mRNA and Protein Expression in the Pathogenesis and Treatment of Major Depression

Sabine Bahn, M.D., Ph.D., M.R.C. Psych.
University of Cambridge
Abnormal T-Cell Function in Schizophrenia Reflects Peripheral Abnormalities and Provides a Means of Detecting Global Deficits in Signalling, Gene Transcription, and Protein Expression

Samuel A. Ball, Ph.D.
Yale University School of Medicine, Yale University
Psychotic-Spectrum Personality Disorders in Homeless Persons

Michael Bauer, M.D., Ph.D.
Charite, University of Berlin
Thyroid Hormone and Mood Modulation in Bipolar Disorder: Neurobiological Mechanisms

Richard G. Boles, M.D.
Children's Hospital, Los Angeles/University of Southern California
mtDNA Sequence Variants and Predisposition Towards Depression

Kelly N. Botteron, M.D.
Washington University
Diffusion Tensor Imaging in Early Onset Affective Disorder: A Twin Study

Todd S. Braver, Ph.D.
Washington University
Improving Prefrontal Cortex Function in Schizophrenia through Focused Training of Cognitive Control

Anne Buist, MBBS, M.Med., M.D., FRANZCP
Austin Hospital/University of Melbourne
Relapse of Bipolar Affective Disorder in the Perinatal Period: Role of Sleep and Circadian Rhythm

William A. Carlezon, Jr., Ph.D.
McLean Hospital/Harvard University
Role of SPROUTY in Neurogenensis and Antidepressant-like Effects in Rats

Gabriel Corfas, Ph.D.
Children's Hospital, Boston Harvard University
Neuregulin 1-erbB Signaling and Schizophrenia

Joseph F. Cubells, M.D., Ph.D.
Emory University School of Medicine
Genetics of Interferon-Alpha-Induced Depression

Faith B. Dickerson, Ph.D., M.P.H.
Sheppard Pratt Health System/University of Maryland
Functional Recovery in Bipolar Disorder: The Role of Neurocognitive Factors

Anne Duffy, M.D.
McGill University
Integrative Prospective Studies Among the Offspring of Well-Characterized Bipolar Parents

Cynthia Neill Epperson, M.D.
Yale University School of Medicine
Serotonin, Neurosteroids and GABA Contributions to SSRI Treatment Response in PMDD: A 1H-MRS Study

Jeffrey D. Erickson, Ph.D.
Louisiana State University Health Sciences Center/Louisiana State University
Scaling of Vesicular Glutamate and GABA Storage in Neocortical Synapses

Monika Fleshner, Ph.D.
University of Colorado, Boulder
Prevention of Negative Behavioral Effects of Acute Fluoxetine: Role of BDNF

Liisa A.M. Galea, Ph.D.
University of British Columbia
Models of Postpartum Depression: Effects on Behavior, Stress Reactivity and Hippocampal Neurogenesis in Both Mother and Offspring

Tony P. George, M.D.
Connecticut Mental Health Center/Yale University
Effects of Galanthamine on Neurocognitive Deficits in Smokers and Non-smokers with Schizophrenia

Howard Gershenfeld, M.D., Ph.D.
University of Texas Southwestern Medical Center at Dallas
Developing Biomarkers for Treatment Resistant Depression

Michael R. James, Ph.D.
Queensland Institute of Medical Research
Genetic Mapping of Schizophrenia Locus on Chromosome 2

Rima F Kaddurah-Daouk, Ph.D.
Duke University Medical Center
Metabolic Signatures of Antipsychotic Drugs in the Treatment of Schizophrenia

Wendy R. Kates, Ph.D.
State University of New York, Upstate Medical University
An fMRI Study of Genetic Modulation of Emotional Processing in Velocardiofacial Syndrome

Ilana Kremer, M.D.
Emek Medical Center Technion-Israel Institute of Technology
Genetic Predisposition to Metabolic Syndrome and Type II Diabetes in Schizophrenic Patients

Mark L. Laudenslager, Ph.D.
University of Colorado at Denver and Health Sciences Center
Salivary Cortisol and DHEA as a Valid Biomarker in Bipolar Disorder: Insights into Outcomes

Daniel Levesque, Ph.D.
Laval University
Identification of Genes Associated with Nur77-Dependent Transcriptional Activity in Antipsychotic Drug Actions

A. Kimberly McAllister, Ph.D.
University of California, Davis
Regulation of NMDAR Trafficking and Function by Class I MHC Molecules

Paul J. Moberg, Ph.D., ABPP
University of Pennsylvania Medical School
Olfactory Dysfunction in Schizophrenia: A Model System to Investigate Aberrant Neurodevelopment

Terence J. O'Brien, M.D.
University of Melbourne
The Effects of Hypercortisolaemia on Limbic Epileptogenesis

Arturas Petronis, M.D., Ph.D.
Centre for Addiction and Mental Health University of Toronto
Epigenomic Profiles in Major Psychiatric Disease: The First 15% of the Genome

Mary Phillips, M.D.
Western Psychiatric Institute and Clinic/University of Pittsburgh
Defining the Neural Markers of Bipolar Disorder: A Functional Neuroimaging Study

Teodor T. Postolache, M.D.
University of Maryland
Relationship between Allergen Specific IgE Antibodies and Exacerbation of Recurrent Mood Disorders

Delbert Robinson, M.D.
The Zucker Hillside Hospital/Albert Einstein College of Medicine of Yeshiva University
Long-Acting Risperidone for Patients who Fail their First Antipsychotic Treatment Trial

Ronnen H. Segman, M.D.
Hadassah University Hospital/Hebrew University
Peripheral Blood Mononuclear Cell Gene Expression Profiling of Postpartum Depressive Disorder

Anne B. Sereno, Ph.D.
University of Texas Health Science Center at Houston
Effects of Dopaminergic Medications on Orienting in Schizophrenia

Yvette I. Sheline, M.D.
Washington University
Decreased White Matter Connectivity in Late Life Depressions

Karen E. Stevens, Ph.D.
University of Colorado at Denver and Health Sciences Center
Gestational Choline Supplementation for the Amelioration of Sensory Inhibition Deficits

Martin H. Teicher, M.D., Ph.D.
McLean Hospital/Harvard University
Early Stress and the Neurobiology of Depression

Anthony D. Wagner, Ph.D.
Stanford University
Declarative Memory in Schizophrenia: fMRI of Hippocampal Subfield Function

Mark Allen Whisman, Ph.D.
University of Colorado, Boulder
Prospective Associations Among Genes, Stress and Depression

Kimberly A. Yonkers, M.D.
Yale University School of Medicine Yale University
A Controlled Study of SSRI Exposure in Neonates

Carlos A. Zarate, M.D.
National Institute of Mental Health (NIMH/NIH)
An Investigation of Glutamatergic Modulators as Pharmacologic Strategies to Bring Rapid (Next Day) and Sustained Antidepressant Effects